Las Condes

81 / 160

81
14. Chiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in
the post-vaccination era. BMC Infect Dis. 2013;13(1):151.
15. WHO. Pertussis vaccines: WHO position paper, August
2015-Recommendations. Vaccine; 2016;34(12):1423–5. Available
from:
16. Vizzotti C, Neyro S, Katz N, Juárez M V., Perez Carrega ME, Aquino
A, et al. Maternal immunization in Argentina: A storyline from the
prospective of a middle income country. Vaccine 2015;33(47):6413–
9.
17. Sukumaran L, McCarthy NL, Kharbanda EO, McNeil MM, Naleway AL,
Klein NP, et al. Association of Tdap Vaccination With Acute Events and
Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-
Containing Immunizations. Jama. 2015;314(15):1581–7.
18. Sawyer, M; Liang, JL; Messonnier, N; Clark T. Updated recommendations
for use of tetanus toxoid, reduced diphtheria toxoid, and acellular
pertussis vaccine (Tdap) in pregnant women--Advisory Committee on
Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep.
2013;62(7):131–5.
19. Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK,
et al. Safety and immunogenicity of tetanus diphtheria and acellular
pertussis (Tdap) immunization during pregnancy in mothers and
infants: a randomized clinical trial. Jama. 2014;311(17):1760–9.
20. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan
K, et al. Effectiveness of maternal pertussis vaccination in England: An
observational study. Lancet. 2014;384(9953):1521–8.
21. Pírez MC, Algorta G, Chamorro F, Romero C, Varela A, Cedres A,
et al. Changes in Hospitalizations for Pneumonia after Universal
Vaccination with Pneumococcal Conjugate Vaccines 7/13 Valent
and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric
Referral Hospital in Uruguay. Pediatr Infect Dis J. 2014;33(7):753–9.
22. Who. Haemophilus influenzae type b (Hib) Vaccination Position
Paper - July 2013. Wkly Epidemiol Rec [Internet]. 2013;(39):413–
28. Available from:
pdf?ua=1,accedido 20 Agosto 2016.
23. Villena R. Vacunas neumocócicas. Alergia e Inmunología Respiratoria
Ed: Quezada A. Primera edición. Santiago, Chile; 2013. p. 395–9.
24. Falleiros-Arlant LH, Berezin EN, Avila-Aguero ML, Pirez MC, Gentile A,
Richardson V, et al. Epidemiological burden of invasive pneumococcal
disease in children and adolescents with predisposing risk factors. Int
J Infect Dis. 2015;38:1–6.
25. Pública I de S. Vigilancia de laboratorio de Streptococcus pneumoniae
prodedente de enfermedad invasora, Chile, 2007 - 2015. Boletín
Inst Salud Pública Chile [Internet]. 2015;5(7):1–17. Available from:
de Vigilancia de
Laboratorio de Streptococcus pneumoniae.pdf, accedido el 10 Agosto
del 2016.
26. Pública I de S. Comportamiento de Streptococcus pneumoniae
serotipos 3 y 19A en Chile, años 2007 - 2015 [Internet]. Santiago,
Chile; 2016. Available from:
Boletin S.pneumoniae 19A y 3.pdf
27. Yildirim I, Shea KM, Pelton SI. Pneumococcal Disease in the Era
of Pneumococcal Conjugate Vaccine. Infect Dis Clin North Am.
2015;29(4):679–97.
28. He Q, Johnston J, Zeitlinger J, City K, City K. Declines in Pneumonia
Hospitalizations of Children Aged <2 Years Associated with the Use
of Pneumococcal Conjugate Vaccines - Tennesse, 1998 - 2012.
2015;33(4):395–401.
29. Madhi SA, Adrian P, Kuwanda L, Jassat W, Jones S, Little T, et al.
Long-term immunogenicity and efficacy of a 9-valent conjugate
pneumococcal vaccine in human immunodeficient virus infected and
non-infected children in the absence of a booster dose of vaccine.
Vaccine. 2007;25(13):2451–7.
30. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S.
hospitalizations for pneumonia after a decade of pneumococcal
vaccination. N Engl J Med 2013;369(2):155–63.
31. WHO. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol
Rec Relev épidémiologique Hebd [Internet]. 2012;87(14):129–44.
Available from: ,
accedido 3 Septiembre 2016.
32. Miwako Kobayashi; Nancy M Bennett; Ryan Gierke; Olivia Almendares;
Matthew R Moore, Cynthia G. Whitney TP. Intervals Between PCV13
and PPSV23 Vaccines: Recommendations of the Advisory Committee
on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep
[Internet]. 2015;64(34):944–7.
33. van Westen E, Wijmenga-Monsuur AJ, van Dijken HH, van Gaans-van
den Brink JAM, Kuipers B, Knol MJ, et al. Differential B cell memory
around the 11-month booster in children vaccinated with a 10-
or 13-valent pneumococcal conjugate vaccine. Clin Infect Dis
2015;61(3):342–9.
34. Falleiros Arlant LH, Bricks LF. Towards improved influenza control
through vaccination. Rev Chil Infectol. 2015;32(2):205–10.
35. Afonso ET, Minamisava R, Bierrenbach AL, Escalante JJC, Alencar
AP, Domingues CM, et al. Effect of 10-valent pneumococcal
vaccine on pneumonia among children, Brazil. Emerg Infect Dis.
2013;19(4):589–97.
36. Tregnaghi MW, Saez-Llorens X, Lopez P, Abate H, Smith E, Pesleman A,
et al. Efficacy of pneumococcal nontypable Haemophilus influenzae
protein D conjugate vaccine (PHiD-CV) in young Latin American
children: A double-blind randomized controlled trial. PLoS Med.
2014;11(6):e1001657.
37. EMA. Anexo I: Ficha técnica o resumen de las características del
producto 1. Keppra 250 mg comprimidos. Agencia Eur Medicam
[Internet]. 2014;1–33. Available from:
documents/community.../anx_130850_es.pdf
38. Assandri E, Amorín B, Gesuele JP, Algorta G, Pírez MC. [Pneumococcal
invasive disease in newborns before and after 7-valent and 13-valent
universal pneumococcal vaccination in Uruguay]. Rev Chilena
Infectol. 2015;32(2):167–74.
39. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, et
al. Serotype-Specific Changes in Invasive Pneumococcal Disease after
Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of
Multiple Surveillance Sites. PLoS Med. 2013;10(9).
40. Marom T, Avraham E, Cinamon U, Tamir SO. The effect of immunization
with pneumococcal conjugated vaccines on Streptococcus
pneumoniae resistance patterns in acute otitis media. J Microbiol
Immunol Infect; 2015;8–11.
41. Lau WCY, Murray M, El-Turki A, Saxena S, Ladhani S, Long P, et al.
Impact of pneumococcal conjugate vaccines on childhood otitis
[VACUNAS E INFECCIONES RESPIRATORIAS - Dr. Rodolfo Villena]